PurePharmas offers high-purity Tirzepatide research vials designed for sophisticated in vitro metabolic and endocrine studies. As a dual-acting glucose-dependent insulinotropic polypeptide GIP and glucagon-like peptide-1 GLP-1 receptor agonist Tirzepatide is a critical compound for researchers investigating the synergistic effects of multi-receptor signaling on glycemic control and energy balance. Our Tirzepatide is synthesized via advanced laboratory protocols to achieve a purity level of 99% or higher as verified by RP-HPLC and mass spectrometry. Each vial contains a lyophilized powder vacuum-sealed in a sterile laboratory environment to ensure maximum stability and molecular integrity throughout the transit process across Europe. As a leading biotech research supply PurePharmas provides a comprehensive Certificate of Analysis with every batch to support experimental accuracy and scientific transparency.